This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Eeckhoute, J. Articles by Laine, B. Search for Related Content PubMed PubMed Citation Articles by Eeckhoute, J. Articles by Laine, B. Pubmed/NCBI databases OMIM Substance via MeSH Medline Plus Health Information Diabetes Genetics Home Reference

Maturity-Onset Diabetes of the Young Type 1 (MODY1)-Associated Mutations R154X and E276Q in Hepatocyte Nuclear Factor 4 (HNF4) Gene Impair Recruitment of p300, a Key Transcriptional Coactivator

Unité 459 INSERM Laboratoire de Biologie Cellulaire Université H. Warembourg Lille, France F 59045

Hepatocyte nuclear factor 4 (HNF4) is a nuclear receptor involved in glucose homeostasis and is required for normal ß-cell function. Mutations in the HNF4 gene are associated with maturity-onset diabetes of the young type 1. E276Q and R154X mutations were previously shown to impair intrinsic transcriptional activity (without exogenously supplied coactivators) of HNF4. Given that transcriptional partners of HNF4 modulate its intrinsic transcriptional activity and play crucial roles in HNF4 function, we investigated the effects of these mutations on potentiation of HNF4 activity by p300, a key coactivator for HNF4. We show here that loss of HNF4 function by both mutations is increased through impaired physical interaction and functional cooperation between HNF4 and p300. Impairment of p300-mediated potentiation of HNF4 transcriptional activity is of particular importance for the E276Q mutant since its intrinsic transcriptional activity is moderately affected. Together with previous results obtained with chicken ovalbumin upstream promoter-transcription factor II, our results highlight that impairment of recruitment of transcriptional partners represents an important mechanism leading to abnormal HNF4 function resulting from the MODY1 E276Q mutation. The impaired potentiations of HNF4 activity were observed on the promoter of HNF1, a transcription factor involved in a transcriptional network and required for ß-cell function. Given its involvement in a regulatory signaling cascade, loss of HNF4 function may cause reduced ß-cell function secondary to defective HNF1 expression. Our results also shed light on a better structure-function relationship of HNF4 and on p300 sequences involved in the interaction with HNF4.

This article has been cited by other articles:

				C. Pramfalk, E. Karlsson, L. Groop, L.L. Rudel, B. Angelin, M. Eriksson, and P. Parini Control of ACAT2 Liver Expression by HNF4{alpha}: Lesson From MODY1 Patients Arterioscler Thromb Vasc Biol, August 1, 2009; 29(8): 1235 - 1241. [Abstract] [Full Text] [PDF]

				P. Ungaro, R. Teperino, P. Mirra, A. Cassese, F. Fiory, G. Perruolo, C. Miele, M. Laakso, P. Formisano, and F. Beguinot Molecular Cloning and Characterization of the Human PED/PEA-15 Gene Promoter Reveal Antagonistic Regulation by Hepatocyte Nuclear Factor 4{alpha} and Chicken Ovalbumin Upstream Promoter Transcription Factor II J. Biol. Chem., November 7, 2008; 283(45): 30970 - 30979. [Abstract] [Full Text] [PDF]

				C. P. Martinez-Jimenez, M. J. Gomez-Lechon, J. V. Castell, and R. Jover Underexpressed Coactivators PGC1{alpha} AND SRC1 Impair Hepatocyte Nuclear Factor 4{alpha} Function and Promote Dedifferentiation in Human Hepatoma Cells J. Biol. Chem., October 6, 2006; 281(40): 29840 - 29849. [Abstract] [Full Text] [PDF]

				C. W. Rowley, L. J. Staloch, J. K. Divine, S. P. McCaul, and T. C. Simon Mechanisms of mutual functional interactions between HNF-4{alpha} and HNF-1{alpha} revealed by mutations that cause maturity onset diabetes of the young Am J Physiol Gastrointest Liver Physiol, March 1, 2006; 290(3): G466 - G475. [Abstract] [Full Text] [PDF]

				J. L. Volinic, J. H. Lee, K. Eto, V. Kaur, and M. K. Thomas Overexpression of the Coactivator Bridge-1 Results in Insulin Deficiency and Diabetes Mol. Endocrinol., January 1, 2006; 20(1): 167 - 182. [Abstract] [Full Text] [PDF]

				V. Stanojevic, J. F. Habener, and M. K. Thomas Pancreas Duodenum Homeobox-1 Transcriptional Activation Requires Interactions with p300 Endocrinology, June 1, 2004; 145(6): 2918 - 2928. [Abstract] [Full Text] [PDF]

				J. Eeckhoute, P. Formstecher, and B. Laine Hepatocyte Nuclear Factor 4{alpha} enhances the Hepatocyte Nuclear Factor 1{alpha}-mediated activation of transcription Nucleic Acids Res., May 11, 2004; 32(8): 2586 - 2593. [Abstract] [Full Text] [PDF]

				V. M. Schwitzgebel, A. Mamin, T. Brun, B. Ritz-Laser, M. Zaiko, A. Maret, F. R. Jornayvaz, G. E. Theintz, O. Michielin, D. Melloul, et al. Agenesis of Human Pancreas due to Decreased Half-Life of Insulin Promoter Factor 1 J. Clin. Endocrinol. Metab., September 1, 2003; 88(9): 4398 - 4406. [Abstract] [Full Text] [PDF]

				R. Hertz, N. Ben-Haim, A. D. Petrescu, B. Kalderon, I. Berman, N. Eldad, F. Schroeder, and J. Bar-Tana Rescue of MODY-1 by Agonist Ligands of Hepatocyte Nuclear Factor-4{alpha} J. Biol. Chem., June 13, 2003; 278(25): 22578 - 22585. [Abstract] [Full Text] [PDF]

				J. Eeckhoute, E. Moerman, T. Bouckenooghe, B. Lukoviak, F. Pattou, P. Formstecher, J. Kerr-Conte, B. Vandewalle, and B. Laine Hepatocyte Nuclear Factor 4{alpha} Isoforms Originated from the P1 Promoter Are Expressed in Human Pancreatic {beta}-Cells and Exhibit Stronger Transcriptional Potentials than P2 Promoter-Driven Isoforms Endocrinology, May 1, 2003; 144(5): 1686 - 1694. [Abstract] [Full Text] [PDF]